These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33032947)

  • 1. Patient-reported barriers to statin adherence: Excerpts from a motivational interviewing intervention in older adults.
    Vadhariya A; Paranjpe R; Essien EJ; Johnson ML; Fleming ML; Esse TW; Gallardo E; Serna O; Choi J; Boklage S; Abughosh SM
    J Am Pharm Assoc (2003); 2021; 61(1):60-67.e1. PubMed ID: 33032947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
    Abughosh SM; Vadhariya A; Johnson ML; Essien EJ; Esse TW; Serna O; Gallardo E; Boklage SH; Choi J; Holstad MM; Fleming ML
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating trajectories of statin adherence after a motivational interviewing intervention.
    Paranjpe R; Vadhariya A; Choi J; Essien EJ; Esse TW; Gallardo E; Serna O; Abughosh S
    J Am Pharm Assoc (2003); 2020; 60(6):892-898. PubMed ID: 32680781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention.
    Majd Z; Mohan A; Johnson ML; Essien EJ; Barner JC; Serna O; Gallardo E; Fleming ML; Ordonez N; Holstad MM; Abughosh SM
    Patient Prefer Adherence; 2022; 16():2739-2748. PubMed ID: 36217375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users.
    Majd Z; Mohan A; Abughosh SM
    J Am Pharm Assoc (2003); 2021; 61(6):829-837.e2. PubMed ID: 34344613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications.
    Mohan A; Vadhariya A; Majd Z; Esse TW; Serna O; Abughosh SM
    Patient Educ Couns; 2021 Jul; 104(7):1756-1764. PubMed ID: 33402279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication.
    Rash JA; Lavoie KL; Sigal RJ; Campbell DJ; Manns BJ; Tonelli M; Campbell TS
    Contemp Clin Trials; 2016 Jul; 49():47-56. PubMed ID: 27282119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
    Boulmpou A; Kartas A; Farmakis I; Zafeiropoulos S; Nevras V; Papadimitriou I; Tampaki A; Vlachou A; Lillis L; Koutsakis A; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2019; 60(4):249-253. PubMed ID: 30352291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
    Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
    Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
    Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
    J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.
    Krüger K; Leppkes N; Gehrke-Beck S; Herrmann W; Algharably EA; Kreutz R; Heintze C; Filler I
    Br J Gen Pract; 2018 Jun; 68(671):e401-e407. PubMed ID: 29686133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy.
    Brinton EA
    Clin Cardiol; 2018 Jun; 41(6):710-720. PubMed ID: 29749101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.
    Calvert SB; Kramer JM; Anstrom KJ; Kaltenbach LA; Stafford JA; Allen LaPointe NM
    Am Heart J; 2012 Apr; 163(4):657-65.e1. PubMed ID: 22520532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
    Renner HM; Hollar A; Stolpe SF; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(3S):S236-S242.e1. PubMed ID: 28506378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivational Interviewing to Increase Postdischarge Antibiotic Adherence in Older Adults with Pneumonia.
    Eyler R; Shvets K; Blakely ML
    Consult Pharm; 2016 Jan; 31(1):38-43. PubMed ID: 26803086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies.
    Putt ME; Reese PP; Volpp KG; Russell LB; Loewenstein G; Yan J; Pagnotti D; McGilloway R; Brennen T; Finnerty D; Hoffer K; Chadha S; Barankay I
    Clin Trials; 2019 Aug; 16(4):399-409. PubMed ID: 31148473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults.
    Vadhariya A; Fleming ML; Johnson ML; Essien EJ; Serna O; Esse T; Choi J; Boklage SH; Abughosh SM
    Am Health Drug Benefits; 2019; 12(4):202-211. PubMed ID: 31428238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.
    Wohlfahrt A; Campos A; Iversen MD; Gagne JJ; Massarotti E; Solomon DH; Feldman CH
    PLoS One; 2018; 13(7):e0200886. PubMed ID: 30024938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.